Sushmita M. Chanda
Corporate Officer/Principal en ALIGOS THERAPEUTICS, INC. .
Perfil
Sushmita M.
Chanda is currently the Executive VP-Translational Safety Sciences at Aligos Therapeutics, Inc. Prior to this, she was the Vice President-Preclinical Development at Alios BioPharma, Inc. from 2010 to 2018.
From 2000 to 2010, she worked at F.
Hoffmann-La Roche Ltd.
as the Senior Director & Head-Nonclinical Safety.
Chanda holds a doctorate degree from the University of Louisiana at Monroe and undergraduate and graduate degrees from Birla Institute of Technology Mesra.
Cargos activos de Sushmita M. Chanda
| Empresas | Cargo | Inicio |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2018 |
Antiguos cargos conocidos de Sushmita M. Chanda.
| Empresas | Cargo | Fin |
|---|---|---|
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/07/2018 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2010 |
Formación de Sushmita M. Chanda.
| Birla Institute of Technology Mesra | Graduate Degree |
| University of Louisiana at Monroe | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALIGOS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Sushmita M. Chanda
